rapid virologic response
Showing 51 - 75 of >10,000
HCV Reinfection in HD Patients Achieving SVR
Recruiting
- Hepatitis C Virus Infection
- +2 more
-
Douliu, Taiwan
- +6 more
Feb 22, 2021
Study of Multidrug-Resistant Patient Outcomes With and Without
Recruiting
- HIV Infections
- Multi-Antiviral Resistance
- No ibalizumab or Pre-ibalizumab treatment
- On ibalizumab treatment
-
Los Angeles, California
- +38 more
Jan 31, 2023
CKD Patients Treated With Nirmatrelvir-ritonavir
Recruiting
- COVID-19
- +2 more
-
Shatin, New Territories, Hong KongPrince of Wales Hospital, Chinese University of Hong Kong
Nov 21, 2022
Oropharyngeal Cancer Trial in Tampa (Radiotherapy fractionation)
Active, not recruiting
- Oropharyngeal Cancer
- Radiotherapy fractionation
-
Tampa, FloridaH Lee Moffitt Cancer Center and Research Institute
Feb 2, 2023
Severe Mpox in Persons With Advanced HIV
Recruiting
- Monkeypox
- +2 more
-
Atlanta, GeorgiaCenters for Disease Control and Prevention
Sep 18, 2023
Contributing Factors for Poor HIV Treatment Response in TB/HIV
Recruiting
- Tuberculosis
- +2 more
- Observational study
-
Kumasi, GhanaKwame Nkrumah University of Science and Technology
Mar 23, 2022
HCV Infection Trial in Phnom Penh (Sofosbuvir/Daclatasvir)
Not yet recruiting
- HCV Infection
-
Phnom Penh, CambodiaClinical Trial Unit (Ctu)
Aug 7, 2023
Near Patient Molecular Testing in Sepsis
Active, not recruiting
- Sepsis
- Systemic Inflammatory Response Syndrome
-
Los Angeles, California
- +2 more
Jul 19, 2022
Early Syphilis, Latent, Serological Relapse After Treatment Trial (Benzathine Penicillin G, Doxycycline Capsule)
Not yet recruiting
- Early Syphilis, Latent, Serological Relapse After Treatment
- Benzathine Penicillin G
- Doxycycline Capsule
- (no location specified)
Oct 1, 2023
Hepatitis C Trial in Baltimore (Patient-Centered Electronic App)
Recruiting
- Hepatitis C
- Patient-Centered Electronic App
-
Baltimore, MarylandJohns Hopkins University
Mar 29, 2022
Sars-CoV2, Covid19 Trial in Toronto (Peginterferon Lambda-1A, Placebo)
Active, not recruiting
- Sars-CoV2
- Covid19
- Peginterferon Lambda-1A
- Placebo
-
Toronto, Ontario, CanadaToronto General Hospital
Apr 4, 2022
type1diabetes, Diabetes, Type 1 Trial in Montreal (Pramlintide, Insulin Lispro, Insulin aspart)
Not yet recruiting
- type1diabetes
- Diabetes Mellitus, Type 1
- Pramlintide
- +3 more
-
Montreal, Quebec, CanadaResearch Institute of the McGill University Health Center
Sep 18, 2023
Hepatitis C, HIV Coinfection Trial in Chennai (Low intensity HCV treatment adherence support, Medium intensity HCV treatment
Recruiting
- Hepatitis C
- HIV Coinfection
- Low intensity HCV treatment adherence support
- +2 more
-
Chennai, Tamil Nadu, IndiaYR Gaitonde Centre for AIDS Research and Education
May 12, 2022
Hepatitis C, Chronic Trial in Taiwan (PEGASYS 180 µg Q1W, P1101 180 µg Q1W, 48 doses, P1101 270µg Q1W, 48 doses)
Completed
- Hepatitis C, Chronic
- PEGASYS 180 µg Q1W
- +3 more
-
Changhua, Taiwan
- +12 more
Oct 7, 2021
Point of Care Ultrasound to Predict Intensive Care Unit
Recruiting
- Sepsis
-
Manhasset, New YorkNorth Shore University Hospital
Sep 14, 2022
Risk Reduction Trial in Cape Town (UTRA, UTRA feedback)
Recruiting
- Risk Reduction
- UTRA
- UTRA feedback
-
Cape Town, Western Cape, South AfricaDesmond Tutu Health Foundation, University of Cape Town
May 17, 2022
Health Behavior Trial in Eugene (Supported Employment)
Not yet recruiting
- Health Behavior
- Supported Employment
-
Eugene, OregonUniversity of Oregon
Aug 8, 2023
Hepatocellular Carcinoma Trial in Villejuif (RAPID procedure)
Not yet recruiting
- Hepatocellular Carcinoma
- RAPID procedure
-
Villejuif, FranceAP-HP, Paul Brousse Hospital
Jul 24, 2023
Atrial Fibrillation New Onset, Atrial Fibrillation Paroxysmal Trial in Seoul (Amiodarone, diltiazem or esmolol)
Terminated
- Atrial Fibrillation New Onset
- Atrial Fibrillation Paroxysmal
- Amiodarone, diltiazem or esmolol
-
Seoul, Korea, Republic ofSeoul National University Hospital
Jul 10, 2023
Hepatitis C, Chronic, Pregnancy; Infection Trial in Pittsburgh (Sofosbuvir/Velpatasvir 400 MG-100 MG Oral Tablet)
Recruiting
- Hepatitis C, Chronic
- Pregnancy; Infection
- Sofosbuvir/Velpatasvir 400 MG-100 MG Oral Tablet
-
Denver, Colorado
- +4 more
Dec 3, 2022
Human Immunodeficiency Virus-type 1 Infection Trial in Worldwide (Rilpivirine, Efavirenz, Tenofovir disoproxil fumarate)
Completed
- Human Immunodeficiency Virus-type 1 Infection
- Rilpivirine
- +3 more
-
Douala, Cameroon
- +17 more
Jan 22, 2021